newsfeed-en
@SachsAssociates
3. Feb 2022 via Twitter
e-Meet Andrew Allen, Co-Founder, President & CEO of @gritstonebio at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns#Sachs_ELSF #lifesciences #partnering #businessdevelopment #bd #licensing #health #investment #startup #healthcare #innovation #biotech #ehealth pic.twitter.com/LDiKYfdPn1— Sachs Associates (@SachsAssociates) February 3, 2022…
@SachsAssociates
2. Feb 2022 via Twitter
NOXXON’s oncology-focused pipeline breaks the tumor protection barrier and blocks tumor repair by neutralizing chemokines in the tumor micro-environment (TME). e-Meet @noxxon_pharma at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns pic.twitter.com/MgkcKn6jOm— Sachs Associates (@SachsAssociates) February 2, 2022
@Design_Hotels
2. Feb 2022 via Twitter
Get the keys to your own Roman pied-à-terre at @grough.luxurysuites, where apartment-style suites sweep entire floors of a 17th-century palazzo, just steps away from the lively Piazza Navona.#DesignHotels #Rome #Italy pic.twitter.com/cxUhpOEL5W— Design Hotels (@Design_Hotels) February 2, 2022
@SachsAssociates
2. Feb 2022 via Twitter
Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. e-Meet @ActinogenMed at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns pic.twitter.com/dOnTAvBYbc— Sachs Associates (@SachsAssociates) February 2, 2022
@aareal
2. Feb 2022 via Twitter
We are pleased to have been working with the experts from @pnp_emea for three years now and to keep developing new cooperation approaches together with start-ups and PropTechs. Worth reading! #PNPTC @zander_henning https://t.co/ZAYuCC4AJY— Aareal Bank Group (@aareal) February 2, 2022
@eurocrowd
1. Feb 2022 via Twitter
With @HousingEurope and @ICLEI, we are joining the @POWERPOOR_EU training on Feb 4 - join us and learn what being energy-poor is, how to recognise it and tackle it, leveraging innovative financing schemes and energy communities: https://t.co/Q2trign4TU— EUROCROWD (@eurocrowd) February 1, 2022
@eurocrowd
1. Feb 2022 via Twitter
Only 3 days left - register now 👇 https://t.co/JsfWdXAFjO— EUROCROWD (@eurocrowd) February 1, 2022
@SachsAssociates
31. Jan 2022 via Twitter
Portal Instruments is a medical device company focused on advanced drug delivery and solving the challenge of self-administering biological medicines with a needle-free injection approach.e-Meet @portalcambridge at #Sachs_EHTFMore info @ https://t.co/jbnxjW3r5f pic.twitter.com/qPt97VLdnu— Sachs Associates (@SachsAssociates) January 31, 2022 …
@SachsAssociates
31. Jan 2022 via Twitter
Radiopharm Theranostics is a clinical stage radiotherapeutics company developing a world-class platform of innovative radiopharmaceutical products for diagnostic and therapeutic applications in areas of high unmet medical need. https://t.co/b7zJA2j8ns@TeamRadioPharm pic.twitter.com/9bCL9o9EhC— Sachs Associates (@SachsAssociates) January 31…
@SachsAssociates
31. Jan 2022 via Twitter
invIOs stands for innovative immuno-oncology and is a privately held biotech company based in Vienna, Austria, focused on the discovery and development of innovative cancer immunotherapies. e-Meet @invIOs_com at #Sachs_ELSFMore info @ https://t.co/b7zJA2j8ns pic.twitter.com/xMEGgGxUSH— Sachs Associates (@SachsAssociates) January 31, 2022